2018
DOI: 10.1038/s41467-018-04901-6
|View full text |Cite|
|
Sign up to set email alerts
|

Synthetic CRISPR-Cas gene activators for transcriptional reprogramming in bacteria

Abstract: Methods to regulate gene expression programs in bacterial cells are limited by the absence of effective gene activators. To address this challenge, we have developed synthetic bacterial transcriptional activators in E. coli by linking activation domains to programmable CRISPR-Cas DNA binding domains. Effective gene activation requires target sites situated in a narrow region just upstream of the transcription start site, in sharp contrast to the relatively flexible target site requirements for gene activation … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

6
242
0
1

Year Published

2019
2019
2022
2022

Publication Types

Select...
5
1
1

Relationship

2
5

Authors

Journals

citations
Cited by 156 publications
(249 citation statements)
references
References 64 publications
6
242
0
1
Order By: Relevance
“…The grey line represents the baseline activity of the J3-J23117-mRFP1 reporter strain containing an empty vector instead of the CRISPRa component plasmid. For comparison, previous CRISPRa data at -81 and -91 are shown on the schematic above the plot 1 . C) The sharp positioning requirements of CRISPRa are observed when targeting a different minimal promoter.…”
Section: S6mentioning
confidence: 99%
“…The grey line represents the baseline activity of the J3-J23117-mRFP1 reporter strain containing an empty vector instead of the CRISPRa component plasmid. For comparison, previous CRISPRa data at -81 and -91 are shown on the schematic above the plot 1 . C) The sharp positioning requirements of CRISPRa are observed when targeting a different minimal promoter.…”
Section: S6mentioning
confidence: 99%
“…To enable these goals, we recently developed a new CRISPR-Cas transcriptional activation (CRISPRa) system that is effective in E. coli. Our system can be combined with CRISPRi gene repression to programmably and flexibly target multiple genes for simultaneous activation and repression 3 . While our CRISPRa system can be used with heterologous genes, an outstanding challenge is to understand the rules that define effective target sites at arbitrary promoters in the genome.…”
Section: Introductionmentioning
confidence: 99%
“…Targeting this complex to a promoter or an open reading frame (ORF) results in gene repression (CRISPRi) 4 . To enable simultaneous activation, we use modified guide RNAs, termed scaffold RNAs (scRNAs), that include a 3' MS2 hairpin to recruit a transcriptional activator fused to the MS2 coat protein (MCP) 3 . We can express multiple gRNAs and scRNAs to inhibit and activate genes simultaneously; gRNAs targeted to a promoter or ORF result in CRISPRi and scRNAs targeted to an appropriate site upstream of a minimal promoter result in CRISPRa.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Nevertheless, eukaryotic CRISPRa is more versatile than bacterial CRISPRa, since more transcriptional activators are known, and their spatial constraints are more relaxed than in bacteria. Bacterial CRISPRa works efficiently in a narrow region of about 90 bp upstream of the transcription start site limiting applicability [164] in addition to the rare occurrence of PAM sequences in this region [157].…”
Section: Limitations Of Crispri and Future Directionsmentioning
confidence: 99%